🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 13 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/04/2017 | 32,54 | 32,78 | 31,52 | 32,61 | +0,22% | 3,87% | 1.685.800 |
| 20/04/2017 | 32,00 | 32,88 | 31,78 | 32,54 | +2,23% | 3,44% | 1.596.500 |
| 19/04/2017 | 31,46 | 32,32 | 30,41 | 31,83 | +1,43% | 6,07% | 1.716.300 |
| 18/04/2017 | 30,92 | 31,72 | 30,36 | 31,38 | +1,95% | 4,40% | 1.667.200 |
| 17/04/2017 | 29,84 | 31,35 | 29,84 | 30,78 | +2,84% | 5,06% | 1.490.200 |
| 13/04/2017 | 29,41 | 30,17 | 29,15 | 29,93 | +1,77% | 3,47% | 1.214.500 |
| 12/04/2017 | 28,29 | 29,89 | 28,16 | 29,41 | +3,52% | 6,12% | 1.721.100 |
| 11/04/2017 | 28,64 | 29,00 | 28,14 | 28,41 | -1,29% | 3,00% | 1.031.700 |
| 10/04/2017 | 28,81 | 29,30 | 28,56 | 28,78 | +0,17% | 2,57% | 983.900 |
| 07/04/2017 | 29,31 | 29,37 | 28,15 | 28,73 | -2,01% | 4,16% | 1.829.400 |
| 06/04/2017 | 29,40 | 29,58 | 28,72 | 29,32 | +0,38% | 2,93% | 1.389.200 |
| 05/04/2017 | 29,90 | 31,16 | 28,89 | 29,21 | +1,46% | 7,59% | 3.554.700 |
| 04/04/2017 | 29,69 | 29,82 | 28,75 | 28,79 | -3,06% | 3,60% | 1.209.700 |
| 03/04/2017 | 29,76 | 30,45 | 29,24 | 29,70 | +0,34% | 4,07% | 1.745.400 |
| 31/03/2017 | 28,94 | 29,67 | 28,78 | 29,60 | +2,03% | 3,08% | 1.140.500 |
| 30/03/2017 | 29,49 | 29,75 | 28,70 | 29,01 | -1,83% | 3,56% | 1.306.000 |
| 29/03/2017 | 29,72 | 30,00 | 29,17 | 29,55 | -0,84% | 2,79% | 1.224.000 |
| 28/03/2017 | 31,50 | 31,54 | 29,33 | 29,80 | -2,49% | 7,02% | 1.777.800 |
| 27/03/2017 | 29,92 | 30,60 | 29,32 | 30,56 | +2,10% | 4,28% | 1.250.400 |
| 24/03/2017 | 29,72 | 30,17 | 29,54 | 29,93 | +0,84% | 2,12% | 856.200 |
| 23/03/2017 | 30,06 | 30,55 | 29,52 | 29,68 | -1,69% | 3,43% | 1.043.200 |
| 22/03/2017 | 29,05 | 30,24 | 28,55 | 30,19 | +4,36% | 5,82% | 1.664.900 |
| 21/03/2017 | 30,60 | 30,85 | 28,80 | 28,93 | -4,99% | 6,70% | 1.581.000 |
| 20/03/2017 | 30,12 | 30,53 | 29,75 | 30,45 | +0,50% | 2,59% | 1.037.200 |
| 17/03/2017 | 30,31 | 30,67 | 29,50 | 30,30 | -0,16% | 3,86% | 2.353.400 |
| 16/03/2017 | 31,56 | 31,73 | 30,07 | 30,35 | -4,05% | 5,26% | 1.412.900 |
| 15/03/2017 | 30,21 | 31,69 | 29,84 | 31,63 | +4,87% | 6,12% | 1.552.400 |
| 14/03/2017 | 31,09 | 31,65 | 29,80 | 30,16 | -3,86% | 5,95% | 1.908.900 |
| 13/03/2017 | 32,21 | 32,95 | 31,36 | 31,37 | -3,86% | 4,94% | 1.674.200 |
| 10/03/2017 | 33,21 | 33,45 | 31,69 | 32,63 | -0,31% | 5,30% | 2.081.800 |